SFAM
Springhill Fund Asset Management Portfolio holdings
AUM
$20.9M
This Quarter Return
+8.77%
1 Year Return
–
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$20.9M
AUM Growth
+$20.9M
(-66%)
Cap. Flow
-$43.7M
Cap. Flow
% of AUM
-209.44%
Top 10 Holdings %
Top 10 Hldgs %
82.88%
Holding
30
New
13
Increased
2
Reduced
4
Closed
11
Top Buys
| 1 |
Summit Therapeutics
SMMT
|
$2.4M |
| 2 |
Regeneron Pharmaceuticals
REGN
|
$1.65M |
| 3 |
Neurocrine Biosciences
NBIX
|
$1.51M |
| 4 |
Janux Therapeutics
JANX
|
$1.32M |
| 5 |
Soleno Therapeutics
SLNO
|
$1.29M |
Top Sells
| 1 |
Legend Biotech
LEGN
|
$6.21M |
| 2 |
Cytokinetics
CYTK
|
$6.15M |
| 3 |
Akero Therapeutics
AKRO
|
$5.31M |
| 4 |
AstraZeneca
AZN
|
$5.01M |
| 5 |
Vera Therapeutics
VERA
|
$4.63M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Dyne Therapeutics
DYN
$1.92B
| – | – |
-131,200
| Closed | -$3.09M |
|
|
27
Legend Biotech
LEGN
$6.41B
| – | – |
-190,800
| Closed | -$6.21M |
|
28
Merus
MRUS
$5.01B
| – | – |
-83,800
| Closed | -$3.52M |
|
29
Nurix Therapeutics
NRIX
$714M
| – | – |
-160,500
| Closed | -$3.02M |
|
|
30
Vera Therapeutics
VERA
$1.44B
| – | – |
-109,400
| Closed | -$4.63M |
|